PLoS ONE (Jan 2020)

An inducible ectopic expression system of EWSR1-FLI1 as a tool for understanding Ewing sarcoma oncogenesis.

  • Daniel J García-Domínguez,
  • Lourdes Hontecillas-Prieto,
  • Eduardo Andrés León,
  • Sara Sánchez-Molina,
  • Pablo Rodríguez-Núñez,
  • Francisco J Morón,
  • Nabil Hajji,
  • Carlos Mackintosh,
  • Enrique de Álava

DOI
https://doi.org/10.1371/journal.pone.0234243
Journal volume & issue
Vol. 15, no. 6
p. e0234243

Abstract

Read online

The presence of the chimeric EWSR1-FLI1 oncoprotein is the main and initiating event defining Ewing sarcoma (ES). The dysregulation of epigenomic and proteomic homeostasis induced by the oncoprotein contributes to a wide variety of events involved in oncogenesis and tumor progression. Attempts at studying the effects of EWSR1-FLI1 in non-tumor cells to understand the mechanisms underlying sarcomagenesis have been unsuccessful to date, as ectopic expression of EWSR1-FLI1 blocks cell cycle progression and induces apoptosis in the tested cell lines. Therefore, it is essential to find a permissive cell type for EWSR1-FLI1 expression that allows its endogenous molecular functions to be studied. Here we have demonstrated that HeLa cell lines are permissive to EWSR1-FLI1 ectopic expression, and that our model substantially recapitulates the endogenous activity of the EWSR1-FLI1 fusion protein. This model could contribute to better understanding ES sarcomagenesis by helping to understand the molecular mechanisms induced by the EWSR1-FLI1 oncoprotein.